Why Orchestra BioMed Holdings, Inc.’s (OBIO) Stock Is Up 5.69%
As of Friday, November 13, Orchestra BioMed Holdings, Inc.’s OBIO share price has surged by 5.69%, which has investors questioning if this is right time to sell.Rosalio Madrigal
| SECTOR | INDUSTRY |
| Health Care | Health Care Equipment & Supplies |
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
Rosalio Madrigal
Rosalio Madrigal
Jenna Brashear
Jenna Brashear
Jenna Brashear
| Share Statistics | OBIO | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $560.0 | $380.3 | 40% |
|
| Shares Out (Mil) | 64.6 | 41.2 | 53% |
|
| Institutional Ownership | 86.8% | 84.0% | 54% |
|
| Float (Mil) | 47.9 | 35.2 | 46% |
|
| Beta | 0.55 | 0.85 | 30% |
|
| Avg Daily Volume (000s) | 724 | 341 | 63% |
|
| Price Change (52-week) |
70.2% | 59.6% | 92% |
|
| Growth | OBIO | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 42.5% | 11.8% | 94% |
|
| Net Income (5yr) | (19.8%) | (5.6%) | 20% |
|
| EPS (5yr) | 36.3% | 10.6% | 86 |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | (45.4%) | (16.0%) | 9% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 5 | 5 | 6 | |
| Current EPS | ($0.340) | ($1.358) | ($1.293) | |
| Month Ago EPS | ($0.413) | ($1.517) | ($1.510) | |
| # Rev Up | 1 | 1 | 0 | |
| # Rev Down | 0 | 1 | 1 | |
| Three Months Ago EPS | ($0.414) | ($1.523) | ($1.516) | |
| Year/Year Chg | 11.8% | 22.5% | (14.2%) | |
| Financials | OBIO | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $31 | $127 | 16% |
|
| Net Income (TTM) (Mil) | ($57) | ($9) | 15% |
|
| EPS (TTM) | ($0.922) | ($0.300) | 21% |
|
| Operating Cash Flow (TTM) (Mil) | ($63) | ($1) | 8% |
|
| Net Cash Flow (TTM) (Mil) | ($14) | $2 | 30% |
|
| Long-Term Debt (Q1) (Mil) | $73 | $25 | 41% |
|
| Enterprise Value (Q1) (Mil) | $553 | $400 | 35% |
|
| Valuation | OBIO | Industry Median |
Percentile (All Stocks) |
|
| P/B | 54.73 | 2.62 | 99% |
|
| P/E | na | 26.0 | na |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 1.3 | na |
|
| Ratios | OBIO | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 99.6% | 59.1% | 96% |
|
| Net Margin | (182.5%) | (4.5%) | 5% |
|
| ROA | (53.6%) | (11.0%) | 11% |
|
| ROE | (221.1%) | (8.5%) | 4% |
|
| Liabilities to Assets | 82.6% | 45.9% | 77% |
|
| F-Score | 4 | 4 | 33% |
|
Orchestra BioMed Holdings, Inc. did not pass any screens on 11/16/2026.
Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.
Ⓒ 2026 American Association of Individual Investors